Main content

    Melanoma Clinical Trials

    Adult Clinical Trials Main Page

    CPMC Cancer Services

    Principal Investigator/Contact InformationProtocol TitlePatient Population Recruitment Period
    Principal Investigator:
    David Minor, MD

    Contact:
    Zeena Salman
    415-600-1654    		A Phase II Study of Sunitinib Therapy for Patients with Metastatic Melanoma and KIT Gene Aberrations (Sutent-Kit)Subjects with Metastatic Melanoma and KIT Gene Aberrations Open
    Principal Investigator:
    David Minor, MD

    Contact:
    Ron Frianeza
    415-600-3027    		Adjuvant immunotherapy with anti_CTLA-4 monoclonal antibody (ipilimumab) versus placebo after complete resection of high-risk Stage III Melanoma: A randomized, double-blind Phase 3 trial of the EORTC Melanoma Group. BMS 184-029 Subjects who have advanced stage III melanomaOpen
    Principal Investigator:
    David Minor, MD

    Contact:
    Ron Frianeza
    415-600-3027    		A Multicenter Treatment Protocol for Compassionate Use of Ipilimumab Monotherapy in Subjects with Unresectable Stage III or Stage IV Melanoma. BMS045
    Visit the Compassionate Use of Ipilimumab Monotherapy study on ClinicalTrials.gov.    		Subjects who have advanced stage III or IV melanoma that cannot be treated with surgeryOpen
    Principal Investigator:
    David Minor, MD

    Contact:
    Ron Frianeza
    415-600-3027    		A Multicenter, Open-Label, Phase II Study of Ipilimumab (MDX-010) Extended-Treatment Monotherapy or Follow-up for Patients Previously Enrolled in Ipilimumab. BMS025Subjects who have advanced melanoma and have received a drug called ipilimumab in an earlier study Closed to Enrollment
    Principal Investigator:
    David Minor, MD

    Contact:
    Zeena Salman
    415-600-1654    		A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study Evaluating the Efficacy of ABT-888 in Combination with Temozolomide Versus Temozolomide Alone in Subjects with Metastatic Melanoma. Abbott: M10-440
    Visit the Temozolomide study on ClinicalTrials.gov.    		 Subjects with Melanoma with cutaneous (relating to the skin) orginsClosed to Enrollment


    updated: 4/1/2010

    Back to top